Source: Mclean Researchers are looking at several ways of treating COVID-19, including trialling antiviral drugs and modulating the immune system When I speak to Carl Heneghan, he is not feeling his best. “I’m on day six now,” he says, of his brush with COVID-19. “And all my family’s had it.” Normally, Heneghan, a professor of …
The hunt for an effective treatment for COVID-19 Read More »
Source: Abigail James / The Pharmaceutical Journal Tapering strips — a roll or strip of small daily pouches containing consecutively slightly lower doses to be taken each day — allow patients to regulate the speed of their dose reduction In 2016, after taking antidepressants for two years, patient James Moore realised that they was doing …
Coronaviruses (CVs) can cause disease in many mammals. Despite the previous SARS and MERS outbreaks (from 2002, and 2012, respectively), there are scant data to inform us about active treatments for CV spread or pathology. Chloroquine (CQ) and hydroxychloroquine (HCQ) are well-known antimalarials, and are also used as anti-inflammatory agents. They have activity against some …
Could chloroquine be effective against COVID-19? Read More »
h5>It is hoped that anti-GM-CSF therapies such as namilumab might play an important role in preventing or reducing deterioration in COVID-19 patients As of this morning – Monday April 5 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 47,806 with 4,934 deaths. Oxford, UK-based biopharma Izana Bioscience has announced …
Izana intiates study assessing namilumab for COVID-19 Read More »
h5>Preclinical testing expected “within weeks” As of this morning – Tuesday April 7 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 51,608 with 5,373 deaths UK biotech Imophoron says it has produced multiple COVID-19 vaccine candidates based on its novel vaccine platform ADDomer. Having joined the University of Bristol’s …
